Avastra (AVS) has caught ABN's eye. Avastra is moving into profitability as it refocuses its business on buying US sleep centres. The industry is highly fragmented, offers numerous acquisition opportunities, and there are some 70 million people in the US that suffer sleep disorders. ABN sees this as a "get on board" story.